autologous tumor cells
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2000 (NCT00912418)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous tumor cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00780988 | Phase 1 | Oct 23, 2008 | Stanford University |
| NCT00116441 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2000 | Cell Genesys |
| NCT00136422 | Phase 1 | Jan 1, 2000 | Harvard University |
| NCT00912418 | N/A | Jan 1, 2000 | University of Virginia |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cell Genesys | For profit | 1 | 1 | 1 | 2000 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2000 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of Virginia | Academic/Hospital | 1 | 1 | 1 | 2000 |
4 organizations
Page 1 / 1